We are attending the Biochemical Society’s Deubiquitylases and Ubl-proteases: from fundamental principles to therapeutic opportunities 2023 from 19th to 21st June in Edinburgh. The meeting will explore the structure and function of DUBs, with a view to understanding their specificity and relationship to biological pathways, reflecting that DUBs are exciting emerging new therapeutic targets in cancer research and neurodegenerative conditions as the first DUB-targeting drugs enter clinical trials.
Our Principal Scientist, Dr João Oliveira will be presenting in the ‘DUBS and ULPS in the Nucleus’ session, 20th June, 17:30-17:50, on the 'Applications of activity-based probes in DUB-focused drug discovery; target engagement and generation of a DUBatlas™'.
Ubiquigent is proud to be an event sponsor.
Register here to join us.